BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, December 22, 2024
See today's BioWorld Asia
Home
» Invitrocue is building personal tumor avatars to transform personalized medicine
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Invitrocue is building personal tumor avatars to transform personalized medicine
Aug. 30, 2017
By
Tamra Sami
No Comments
PERTH, Australia – A new technology spun out of Singapore's Agency for Science, Technology and Research (A*STAR) could change cancer treatment by building cell-based tumor avatars in the lab to test them against a multitude of drugs.
BioWorld Asia